| Fahad Chaudhary, MD | |
|
1202 Medical Center Dr, Wilmington, NC 28401-7307 | |
| (910) 341-3300 | |
| Not Available |
| Full Name | Fahad Chaudhary |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 1202 Medical Center Dr, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831540186 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nhrmc Home Care | Rocky point, NC | Home health agency |
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wilmington Health Pllc | 6103722509 | 283 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
MEDICA 2016 (14 – 17 November, Dusseldorf, Germany) is attracting a high level of British healthcare technology companies keen to develop and nurture worldwide trade links post Brexit.
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
› Verified 3 days ago
| Entity Name | Wilmington Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881632339 PECOS PAC ID: 6103722509 Enrollment ID: O20031208000800 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
MEDICA 2016 (14 – 17 November, Dusseldorf, Germany) is attracting a high level of British healthcare technology companies keen to develop and nurture worldwide trade links post Brexit.
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fahad Chaudhary, MD 1202 Medical Center Dr, Wilmington, NC 28401-7307 Ph: (910) 341-3300 | Fahad Chaudhary, MD 1202 Medical Center Dr, Wilmington, NC 28401-7307 Ph: (910) 341-3300 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
Vanderbilt University Medical Center has been chosen as one of 12 sites in the United States to offer the first FDA-approved bionic eye for the treatment of retinitis pigmentosa (RP).
MEDICA 2016 (14 – 17 November, Dusseldorf, Germany) is attracting a high level of British healthcare technology companies keen to develop and nurture worldwide trade links post Brexit.
The NCD Alliance has welcomed More Active People for a Healthier World, the new WHO Global Action Plan for Physical Activity 2018-2030, launched today in Lisbon, saying it has the potential to prevent huge numbers of deaths and disability from noncommunicable diseases across the globe.
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
› Verified 3 days ago
Dr. James Carden Mccabe, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1302 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-9800 Fax: 910-343-9800 | |
Michael Mundy Ward, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2215 Canterwood Dr, Wilmington, NC 28401 Phone: 910-762-4600 Fax: 910-762-9483 | |
Latessa Spiers, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1960 S 16th St, Wilmington, NC 28401 Phone: 910-343-9991 | |
Dr. Kavita S Persaud, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5919 Oleander Dr Ste 109, Wilmington, NC 28403 Phone: 910-799-5508 Fax: 910-202-0654 | |
Dr. Regina Marie Jensen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4536 Technology Dr, Ste 3, Wilmington, NC 28405 Phone: 910-343-8411 Fax: 910-343-8414 | |
Mary Kathryn Rudyk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1709 S 16th St Ste A, Wilmington, NC 28401 Phone: 910-452-8633 Fax: 910-452-8569 | |
Gregory Roberts, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-341-7946 |